Preimplantation Genetic Testing: Where We Are Today

I-36: Preimplantation Genetic Diagnosis - Where Have We Been and Where Are We Going

Preimplantation genetic diagnosis (PGD) is now considered routine in IVF laboratories with micromanipulation capability and access to genetic diagnostic services. The past two decades have witnessed a dramatic increase in the use of PGD, the number of cycles performed, and the indications for which PGD has been used. This increase has been mirrored by a slow, but steady, increase in the range o...

Varenicline : Where are we today ?

In 2006, Chantix (varenicline) splashed boldly onto the nicotine cessation medication scene with full Food and Drug Administration (FDA) approval following the completion of three distinct Pfizer-funded clinical trials (Jorenby et al., 2006; Gonzales et al., 2006; Tonstad et al., 2006). Almost immediately, however, and contrary to the initial findings supporting the safety and efficacy of varen...

Dengue: where are we today?

Dengue is considered the main arthropod-borne viral disease of humans. In the last few years, an increasing number of reports of mild and severe cases have been reported. The growing dengue incidence observed in recent years has been accompanied by reports of new observations, findings and global initiatives with an improvement in our understanding of this phenomenon. The epidemiology and new c...

Where are we going with preimplantation genetic diagnosis?

Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?

N;